Halper Sadeh Launches Investigations into BCO, SEM, and NATL Mergers

The firm is currently reviewing The Brink's Company (NYSE: BCO) regarding its merger with NCR Atleos Corporation, a deal structured to leave Brink’s shareholders with approximately 78% of the combined entity. Simultaneously, the investigation targets the sale of Select Medical Holdings Corporation (NYSE: SEM) to an executive-led consortium for $16.50 per share, alongside the acquisition of NCR Atleos Corporation (NYSE: NATL) for a mix of $30.00 in cash and 0.1574 Brink’s shares per unit.

Legal representatives suggest these transactions may contain restrictive terms that hinder superior bids or fail to provide adequate consideration for public investors. Halper Sadeh LLC, based at One World Trade Center, intends to seek increased compensation or enhanced disclosures to address potential breaches of fiduciary duty. Shareholders affected by these developments are encouraged to examine their legal options, as the firm operates on a contingent fee basis for these inquiries.